Treatment of inflammation and sepsis with hCG derived peptides

摘要

The invention provides use of a gene-regulatory peptide or functional analogue thereof for the production of a pharmaceutical composition for the treatment of a disease comprising an inflammatory condition and/or a counter-inflammatory condition wherein a subject suffering from said disease is subjected to a diagnostic process aimed at determining inflammatory disease stage of said subject and where treatment is selected depending on the outcome of said determination of disease stage.